State Street’s Theriva Biologics TOVX Stock Holding History

State Street’s Portfolio TOVX Stock Details TOVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,948	Closed	-$11.5K	–	4338
2024 Q2	$11.5K	Hold	1,948	–	–	﹤0.01%	4317
2024 Q1	$22.8K	Hold	1,948	–	–	﹤0.01%	4282
2023 Q4	$20.9K	Hold	1,948	–	–	﹤0.01%	4337
2023 Q3	$26.3K	Hold	1,948	–	–	﹤0.01%	4411
2023 Q2	$48.7K	Hold	1,948	–	–	﹤0.01%	4426
2023 Q1	$34K	Hold	1,948	–	–	﹤0.01%	4603
2022 Q4	$22.1K	Hold	1,948	–	–	﹤0.01%	4715
2022 Q3	$48K	Hold	1,948	–	–	﹤0.01%	4666
2022 Q2	$104K	Hold	1,948	–	–	﹤0.01%	4514
2022 Q1	$139K	Buy	1,948 +60	+3%	+$4.09K	﹤0.01%	4522
2021 Q4	$128K	Hold	1,888	–	–	﹤0.01%	4515
2021 Q3	$217K	Hold	1,888	–	–	﹤0.01%	4327
2021 Q2	$284K	Buy	+1,888	New	+$271K	﹤0.01%	4079
2018 Q3	–	Sell	-6	Closed	-$13K	–	3801
2018 Q2	$13K	Hold	6	–	–	﹤0.01%	3750
2018 Q1	$17K	Hold	6	–	–	﹤0.01%	3724
2017 Q4	$26K	Hold	6	–	–	﹤0.01%	3679
2017 Q3	$50K	Hold	6	–	–	﹤0.01%	3665
2017 Q2	$31K	Sell	6 -103	-94%	-$513K	﹤0.01%	3625
2017 Q1	$605K	Hold	109	–	–	﹤0.01%	3357
2016 Q4	$727K	Buy	109 +1	+0.9%	+$10.3K	﹤0.01%	3340
2016 Q3	$1.64M	Buy	108 +8	+8%	+$120K	﹤0.01%	3050
2016 Q2	$1.57M	Buy	100 +94	+1,567%	+$1.77M	﹤0.01%	3119
2016 Q1	$127K	Hold	6	–	–	﹤0.01%	3532
2015 Q4	$123K	Hold	6	–	–	﹤0.01%	3532
2015 Q3	$119K	Hold	6	–	–	﹤0.01%	3520
2015 Q2	$149K	Hold	6	–	–	﹤0.01%	3513
2015 Q1	$115K	Buy	+6	New	+$107K	﹤0.01%	3535

Other funds holding TOVX

HCM

Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street's TOVX Position: Q3 2024 in Review

State Street sold out of Theriva Biologics (TOVX) in Q3 2024, closing a stake of 1,948 shares — an estimated $11.5K sold.

State Street first reported a position in TOVX in Q1 2015 and held it in 27 quarters. The position peaked at $1.64M in Q3 2016. 18 funds tracked by Wall St. Rank hold TOVX as of Q3 2024.

State Street reported no remaining Theriva Biologics position as of Q3 2024 after selling out during the quarter.
State Street sold 1,948 Theriva Biologics shares in Q3 2024, an estimated $11.5K.
State Street first reported a position in Theriva Biologics in Q1 2015 and held it in 27 quarters.
State Street's Theriva Biologics position peaked at $1.64M in Q3 2016.
18 funds tracked by Wall St. Rank held Theriva Biologics as of Q3 2024.

Based on State Street's 13F filing for Q3 2024, filed 14 Nov 2024.